Clinical Trials Browser

Phase 2/3 × Breast Neoplasms × apatinib × Clear all

NCT04803539 2023-02-21

Artemis

Phase 2/3 Recruiting

Breast Neoplasms

NCT03580395 2021-07-09

Apatinib in Neoadjuvant Therapy for Patients With Breast Cancer

Phase 2/3 Unknown

Breast Neoplasms